Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Sève

Showing results (1-10 of 198) with videos related to

Pageof 20
Sort By:
La Revue De Medecine Interne|January 7, 2026
[History of internal medicine in France]Pascal Sève
The Lancet. Oncology|February 2, 2008
Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents?Pascal Sève, Charles Dumontet
Current Medicinal Chemistry. Anti-Cancer Agents|February 22, 2005
Chemoresistance in non-small cell lung cancerPascal Sève, Charles Dumontet
Lung Cancer (Amsterdam, Netherlands)|October 16, 2009
The role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancerPascal Sève, Tony Reiman, Charles Dumontet
Ophthalmology|July 24, 2018
Re: Dick et al.: Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative (Ophthalmology. 2018;125:757-773)Yvan Jamilloux, David Saadoun, Pascal Sève
Rheumatology International|January 13, 2005
Effectiveness of colchicine in a case of recurrent compressive rheumatoid pericarditisPascal Sève, Katia Stankovic, Christiane Broussolle
The Lancet. Rheumatology|August 25, 2020
Intravenous anakinra for cytokine storm syndromesYvan Jamilloux, Mathieu Gerfaud-Valentin, Pascal Sève
Clinical Chemistry|March 30, 2016
CommentaryYvan Jamilloux, Mathieu Gerfaud-Valentin, Pascal Sève
La Revue De Medecine Interne|January 28, 2026
[Workload, institutional recognition, and sleep: A survey of burnout among French internists]Thomas El Jammal, Pascal Sève, Yvan Jamilloux
Autoimmunity Reviews|April 8, 2014
Sarcoidosis and uveitisYvan Jamilloux, Laurent Kodjikian, Christiane Broussolle, et al.
Pageof 20

Showing results (1-10 of 198) with videos related to

Sort By:
Pageof 20
La Revue De Medecine Interne|January 7, 2026
[History of internal medicine in France]Pascal Sève
The Lancet. Oncology|February 2, 2008
Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents?Pascal Sève, Charles Dumontet
Current Medicinal Chemistry. Anti-Cancer Agents|February 22, 2005
Chemoresistance in non-small cell lung cancerPascal Sève, Charles Dumontet
Lung Cancer (Amsterdam, Netherlands)|October 16, 2009
The role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancerPascal Sève, Tony Reiman, Charles Dumontet
Ophthalmology|July 24, 2018
Re: Dick et al.: Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative (Ophthalmology. 2018;125:757-773)Yvan Jamilloux, David Saadoun, Pascal Sève
Rheumatology International|January 13, 2005
Effectiveness of colchicine in a case of recurrent compressive rheumatoid pericarditisPascal Sève, Katia Stankovic, Christiane Broussolle
The Lancet. Rheumatology|August 25, 2020
Intravenous anakinra for cytokine storm syndromesYvan Jamilloux, Mathieu Gerfaud-Valentin, Pascal Sève
Clinical Chemistry|March 30, 2016
CommentaryYvan Jamilloux, Mathieu Gerfaud-Valentin, Pascal Sève
La Revue De Medecine Interne|January 28, 2026
[Workload, institutional recognition, and sleep: A survey of burnout among French internists]Thomas El Jammal, Pascal Sève, Yvan Jamilloux
Autoimmunity Reviews|April 8, 2014
Sarcoidosis and uveitisYvan Jamilloux, Laurent Kodjikian, Christiane Broussolle, et al.
Pageof 20